Why MoonLake Immunotherapeutics Shares Are Surging Higher Today

MoonLake Immunotherapeutics MLTX shares are trading approximately 23% higher Tuesday morning on high volume.

MoonLake's average session volume over a 100-day period is about 158,900, according to data from Benzinga Pro. Tuesday's trading volume has already exceeded 113,400 at the time of publication.

MoonLake Immunotherapeutics is a clinical-stage biopharmaceutical company engaged in leveraging Nanobody technology to develop next-level medicines for immunologic diseases, including inflammatory skin and joint diseases

MLTX Price Action: MoonLake has traded between $4.25 and $15.19 over a 52-week period.

The stock was up 23% at $7.84 at press time.

Market News and Data brought to you by Benzinga APIs
Comments
Loading...
Posted In: MoversTrading Ideaswhy it's moving
Benzinga simplifies the market for smarter investing

Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.

Join Now: Free!